BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23574985)

  • 1. Tolerability and outcomes of radiotherapy or chemoradiotherapy for rectal cancer in elderly patients aged 70 years and older.
    Cai X; Wu H; Peng J; Zhu J; Cai S; Cai G; Zhang Z
    Radiat Oncol; 2013 Apr; 8():86. PubMed ID: 23574985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the Charlson Comorbidity Index a Prognostic Indicator for Toxicity and Mortality in Elderly Patients with Locally Advanced Rectal Cancer?
    Köstek O; Bozkaya Y; Hacıoğlu MB; Yıldırım Özdemir N; Yılmaz E; Demircan NC; Erdoğan B; Uzunoğlu S; Çiçin İ; Zengin N
    Arch Iran Med; 2019 May; 22(5):236-241. PubMed ID: 31256595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative Chemoradiotherapy for Rectal Cancer in Patients Aged 75 Years and Older: Acute Toxicity, Compliance with Treatment, and Early Results.
    Guimas V; Boustani J; Schipman B; Lescut N; Puyraveau M; Bosset JF; Servagi-Vernat S
    Drugs Aging; 2016 Jun; 33(6):419-25. PubMed ID: 27138958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes in elderly rectal cancer patients treated with neoadjuvant chemoradiotherapy: impact of tumor regression grade : Tumor regression grade after neoadjuvant chemoradiotherapy in elderly rectal cancer patients.
    Rosa C; Di Tommaso M; Caravatta L; Taraborrelli M; Gasparini L; Di Guglielmo FC; Delli Pizzi A; Cinalli S; Marchioni M; Di Nicola M; Lanci C; Ausili Cefaro G; Genovesi D
    J Cancer Res Clin Oncol; 2021 Apr; 147(4):1179-1188. PubMed ID: 33026518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe weight loss during preoperative chemoradiotherapy compromises survival outcome for patients with locally advanced rectal cancer.
    Lin J; Peng J; Qdaisat A; Li L; Chen G; Lu Z; Wu X; Gao Y; Zeng Z; Ding P; Pan Z
    J Cancer Res Clin Oncol; 2016 Dec; 142(12):2551-2560. PubMed ID: 27613188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative chemoradiotherapy for elderly patients with locally advanced rectal cancer-a real-world outcome study.
    Choi Y; Kim JH; Kim JW; Kim JW; Lee KW; Oh HK; Kim DW; Kang SB; Song C; Kim JS
    Jpn J Clin Oncol; 2016 Dec; 46(12):1108-1117. PubMed ID: 27655903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of neoadjuvant chemoradiotherapy followed by total mesorectal excision surgery for locally advanced rectal cancer: a single-institution experience.
    Tseng MSF; Zheng H; Ng IWS; Leong YH; Leong CN; Yong WP; Cheong WK; Tey JCS
    Singapore Med J; 2018 Jun; 59(6):305-310. PubMed ID: 29167909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility and efficacy of chemoradiotherapy for elderly patients with locoregionally advanced nasopharyngeal carcinoma: results from a matched cohort analysis.
    Liu H; Chen QY; Guo L; Tang LQ; Mo HY; Zhong ZL; Huang PY; Luo DH; Sun R; Guo X; Cao KJ; Hong MH; Mai HQ
    Radiat Oncol; 2013 Mar; 8():70. PubMed ID: 23521779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative chemoradiotherapy improves local recurrence free survival in locally advanced rectal cancer.
    Tural D; Ozturk M; Selcukbiricik F; Yildiz O; Elicin O; Turna H; Guney S; Ozguroglu M
    J BUON; 2013; 18(2):385-90. PubMed ID: 23818350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerability of combined modality therapy for rectal cancer in elderly patients aged 75 years and older.
    Margalit DN; Mamon HJ; Ancukiewicz M; Kobayashi W; Ryan DP; Blaszkowsky LS; Clark J; Willett CG; Hong TS
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e735-41. PubMed ID: 21377289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerability of Oxaliplatin-based Neoadjuvant Chemoradiotherapy in Elderly Locally Advanced Rectal Cancer Patients: A Case-control Study of a Real-life Experience.
    DE Felice F; Siniscalchi B; Bulzonetti N; Caiazzo R; Musio D; Tombolini V
    Anticancer Res; 2019 Dec; 39(12):6957-6963. PubMed ID: 31810967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Outcomes of Preoperative Chemoradiotherapy and Selective Postoperative Chemoradiotherapy in Clinical Stage T3N0 Low and Mid Rectal Cancer.
    Lin Y; Lin H; Xu Z; Zhou S; Chi P
    J Invest Surg; 2019 Nov; 32(7):679-687. PubMed ID: 30215538
    [No Abstract]   [Full Text] [Related]  

  • 13. [Efficacy analysis of radiotherapy combined with surgery for locally advanced rectal mucinous adenocarcinoma: a retrospective study based on data of Surveillance, Epidemiology, and End results population].
    Zhang Y; Wang X; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Sun Y; Ye D
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):85-93. PubMed ID: 30703799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and prognosis of elderly nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy.
    Lyu Y; Ni M; Zhai R; Kong F; Du C; Hu C; Ying H
    Eur Arch Otorhinolaryngol; 2021 Jul; 278(7):2549-2557. PubMed ID: 33021689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of neoadjuvant short-course radiotherapy and delayed surgery versus chemoradiation on postoperative outcomes in locally advanced rectal cancer patients - A propensity score matched nationwide audit-based study.
    Hoendervangers S; Sparreboom CL; Intven MPW; Lange JF; Verkooijen HM; Doornebosch PG; van Grevenstein WMU;
    Eur J Surg Oncol; 2020 Sep; 46(9):1605-1612. PubMed ID: 32192792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes and prognostic factors of selective lateral pelvic lymph node dissection with preoperative chemoradiotherapy for locally advanced rectal cancer.
    Matsuda T; Sumi Y; Yamashita K; Hasegawa H; Yamamoto M; Matsuda Y; Kanaji S; Oshikiri T; Nakamura T; Suzuki S; Kakeji Y
    Int J Colorectal Dis; 2018 Apr; 33(4):367-374. PubMed ID: 29442155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determining therapeutic approaches in the elderly with rectal cancer.
    Pasetto LM; Basso U; Friso ML; Pucciarelli S; Agostini M; Rugge M; Sinigaglia G; Lise M; Sotti G; Monfardini S
    Drugs Aging; 2007; 24(9):781-90. PubMed ID: 17727307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Comorbidities in Stage II/III Colorectal Cancer Patients Treated With Surgery and Neoadjuvant/Adjuvant Chemotherapy: A Single-Center, Observational Study.
    Baretti M; Rimassa L; Personeni N; Giordano L; Tronconi MC; Pressiani T; Bozzarelli S; Santoro A
    Clin Colorectal Cancer; 2018 Sep; 17(3):e489-e498. PubMed ID: 29650416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
    Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
    [No Abstract]   [Full Text] [Related]  

  • 20. Different Impacts of Preoperative Radiotherapy and Chemoradiotherapy on Oncological Outcomes in Patients with Stages II and III Lower Rectal Cancer: A Propensity Score Analysis.
    Takiyama H; Kawai K; Ishihara S; Yasuda K; Otani K; Nishikawa T; Tanaka T; Kiyomatsu T; Hata K; Nozawa H; Morikawa T; Watanabe T
    Dig Surg; 2018; 35(3):212-219. PubMed ID: 28637039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.